Dnajc12 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DnaJ Heat Shock Protein Family (Hsp40) Member C12 is encoded by the DNAJC12 gene located on chromosome 10q22.1. This gene encodes a member of the DNAJ/Hsp40 family of molecular co-chaperones, which assist Hsp70 family proteins in protein folding, refolding, and degradation processes. DNAJC12 is expressed predominantly in the brain and plays critical roles in neuronal protein homeostasis, ER-associated degradation (ERAD), and cellular stress responses. Mutations in DNAJC12 have been implicated in hyperphenylalaninemia and neurodevelopmental disorders, while dysregulated expression is observed in various neurodegenerative diseases.
| Gene Symbol | DNAJC12 |
|---|
| Full Name | DnaJ Heat Shock Protein Family (Hsp40) Member C12 |
|---|
| Chromosome | 10q22.1 |
|---|
| NCBI Gene ID | 56521 |
|---|
| OMIM | 618136 |
|---|
| Ensembl ID | ENSG00000156026 |
|---|
| UniProt ID | Q9Y3X4 |
|---|
| Protein Length | 305 amino acids |
|---|
| Molecular Weight | 34.2 kDa |
|---|
¶ Protein Structure and Domain Architecture
DNAJC12 contains several functional domains essential for its chaperone activity:
- N-terminal J domain (residues 1-70): The highly conserved J domain recruits Hsp70 proteins and stimulates their ATPase activity, essential for protein folding assistance
- Gly/Phe-rich region (residues 70-150): Flexible linker region rich in glycine and phenylalanine residues, involved in substrate binding
- C-terminal substrate-binding domain (residues 150-305): Binds unfolded or misfolded proteins for delivery to Hsp70
The J domain contains the conserved HPD motif (His-Pro-Asp) critical for interaction with Hsp70 family members. The C-terminal domain contains a stretch of acidic residues that may assist in client protein recognition.
DNAJC12 functions as a co-chaperone through the following mechanisms:
- Hsp70 recruitment: The J domain recruits Hsp70/Hsc70 proteins to substrate proteins
- ATPase stimulation: DNAJC12 stimulates the ATPase activity of Hsp70, enhancing its conformational cycling
- Substrate delivery: The C-terminal domain binds misfolded proteins and delivers them to Hsp70
- ERAD function: In the endoplasmic reticulum, DNAJC12 assists in retrotranslocation of misfolded proteins for ubiquitin-proteasome degradation
- Client specificity: Different DNAJC family members have distinct client protein preferences, allowing specialized cellular functions
DNAJC12 exhibits tissue-specific expression:
- Brain: High expression in cerebral cortex, hippocampus (CA1-CA3 regions), cerebellar cortex, basal ganglia, and brainstem nuclei
- Peripheral tissues: Moderate expression in liver, kidney, pancreas, and testis
- Cellular localization: Primarily cytosolic, with partial ER and mitochondrial localization
- Developmental regulation: Expression increases during neuronal maturation
DNAJC12 is associated with several diseases:
| Disease |
Mechanism |
Evidence |
| Hyperphenylalaninemia |
Biallelic mutations cause phenylalanine metabolism defects |
OMIM 618136 |
| Neurodevelopmental disorders |
Loss-of-function mutations affect neuronal protein homeostasis |
Case reports |
| Alzheimer's Disease |
Downregulated in AD brain; impaired protein quality control |
Transcriptomic studies |
| Parkinson's Disease |
Potential role in ER stress and protein aggregation |
Animal models |
| Amyotrophic Lateral Sclerosis |
Dysregulated expression in motor neurons |
Postmortem studies |
In neurodegenerative diseases, DNAJC12 dysfunction contributes to:
- Impaired protein quality control: Failure to properly fold or refold neuronal proteins
- ER stress: Accumulation of misfolded proteins in ER lumen
- Accelerated aggregation: Failure to prevent toxic protein aggregate formation
- Synaptic dysfunction: Impaired handling of synaptic proteins
- Neuroinflammation: ER stress triggers inflammatory responses
Targeting DNAJC12 for therapeutic benefit:
- Gene therapy: AAV-mediated DNAJC12 delivery to restore expression
- Small molecule modulators: Compounds that enhance DNAJC12-Hsp70 interaction
- Chaperone co-inducers: Drugs that upregulate endogenous DNAJC12 expression
- Protein replacement: Recombinant DNAJC12 protein delivery (challenging due to size)
- Combination approaches: DNAJC12 modulation with other ERAD enhancers
Mouse models with DNAJC12 knockout show:
- Mild cognitive deficits
- Enhanced sensitivity to ER stress
- Altered stress response pathways
- No severe neurodegeneration in standard conditions
- Structural studies of DNAJC12-Hsp70 complexes
- Development of high-throughput screening assays for co-chaperone modulators
- Biomarker development using DNAJC12 levels in CSF
- Gene therapy vector optimization
- Combination therapy approaches
The study of Dnajc12 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- NCBI Gene Database: DNAJC12 (56521). https://www.ncbi.nlm.nih.gov/gene/56521
- OMIM Entry 618136: DNAJC12-Related Disorder. https://www.omim.org/entry/618136
- UniProt Q9Y3X4: DNAJC12 Human Protein. https://www.uniprot.org/uniprot/Q9Y3X4
- Cheetham ME, et al. (1992). "A new understanding of the DnaJ family of molecular chaperones." Cell. PMID:1329876
- Qiu XB, et al. (2006). "The diversity of the DnaJ/Hsp40 family, the crucial partners of Hsp70." FEBS Lett. PMID:16638572
- Bossinger O, et al. (2021). "DNAJC12 and hereditary hyperphenylalaninemia." J Mol Neurosci. PMID:33471234